Study opens new door for ALS drug discovery

Researchers have discovered the first-ever evidence-based description of the neuronal protein clumps thought to be important in Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, a fatal neurodegenerative condition. This research development could be a crucial step toward developing drugs to stop the creation of the clumps and stem the progression of the disease, they say.